Back

Targeting titin in dilated cardiomyopathy

1 September 2024 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: New treatment targets for personalised therapy in genetic cardiomyopathies Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Wolfgang Linke

University Hospital Munster - UKM, Muenster (Germany)

4 More presentations in this session

Presentation thumbnail
Myosin activators for cardiomyopathy: all is not lost
Professor Z. Papp (Debrecen, HU)
Slides Video
Presentation thumbnail
Myosin inhibitors as novel drugs for hypertrophic cardiomyopathy
Professor J. van der Velden (Amsterdam, NL)
Slides Video
Presentation thumbnail
Targeting desmosomal adhesion to treat arrhythmogenic cardiomyopathy
Assistant Professor C. Schinner (Bern, CH)
Slides Video
Presentation thumbnail
New treatment targets for personalised therapy in genetic cardiomyopathies - discussion
Video

Access the full session

Session thumbnail
New treatment targets for personalised therapy in genetic cardiomyopathies
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Modulating TTN gene expression in human iPSC-CMs to investigate mechanisms and therapies in TTN-associated dilated cardiomyopathy
thumbnail
Congress Presentation
Titin truncating variants impair myocardial thick-filament activation during stretch and blunt length-dependent activation mediating Frank-Starling
thumbnail
Congress Session
New treatment targets for personalised therapy in genetic cardiomyopathies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources